IM Cannabis Corp. (IMCC) vs cbdMD, Inc. (YCBD)
- IM Cannabis Corp. IMCC 1.36 +2.26%
- cbdMD, Inc. YCBD 0.35 −2.78%
IM Cannabis Corp. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. cbdMD, Inc. is the larger, with a market value of $4.0M against $2.2M — 1.8× the size. IM Cannabis Corp. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 41.2×. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −12.0%. cbdMD, Inc. has the higher net margin (−14.7% vs −38.9%) and the lower return on invested capital (−29.8% vs 0.00%). Across the 17 metrics below, cbdMD, Inc. leads on 9 and IM Cannabis Corp. on 8.
Valuation
Profitability
| Metric | IMCC | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 12.62% | 57.68% | 53.94% |
| Operating margin | (32.88%) | (13.87%) | 0.00% |
| Net margin | (38.92%) | (14.71%) | 0.00% |
| Free cash flow margin | (1.47%) | (11.51%) | 0.00% |
| Return on equity | 2,280.06% | (43.01%) | (0.40%) |
| Return on assets | (54.20%) | (26.73%) | (3.32%) |
| Return on invested capital | 0.00% | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack